ARCHIVES

RFA On Breast Tumor Factors Patients Survival

This article is from The Cancer Letter archive.

Vol. 06 No. 25 | June 20, 1980

Download PDF Visit The Full Archive

Related Articles

FDA Approves Avastin Combination For Late-Stage Cervical Cancer

August 29, 2014

Bristol-Myers Runs Afoul Of FDA In Attempt To Distribute Chapters of Oncology Textbook

June 19, 1992

Guest Editorial: Richard Schilsky Reflects On His Past Decade WithThe Board of Scientific Advisors

June 24, 2011

NCI-Approved Clinical Trials

July 29, 2005

NCI Reportedly Gets $691 Million From House, Senate Conferees

October 4, 1974

NCI TO Issue RFA For Gene Therapy Studies; $20 Mil. Se-Aside Ok’d

January 10, 1992